NCT02422030View on ClinicalTrials.gov

CKD-337(2) Drug-drug Interaction Study

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 17, 2015

Primary Completion Date

March 22, 2015

Study Completion Date

April 30, 2015

Conditions
Healthy
Interventions
DRUG

Lipitor Tab. 40mg

DRUG

Trilipix 135mg

Trial Locations (1)

561-712

Chonbuk National University Hospital, Deokjin-gu

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY